Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Joint Action

Joint Action artwork

In Memoriam: Prof Frank Beier - new insights into osteoarthritis onset (2021)

Sep 14, 202529 minAudio
ShareXLinkedInFacebookWhatsAppEmail

This week's episode is in honour of Frank Beier, who recently passed away on July 18, 2025. Frank leaves behind a remarkable legacy through the impact he made in the field of osteoarthritis. In this previous episode (2021), he discussed the recent advances in osteoarthritis understanding with a particular emphasis on novel targets and epigenetics. Despite the large prevalence of osteoarthritis, there is no clinically approved drug which provides a cure. Currently, drugs focus on relieving symptoms such as pain. Experiments done in the laboratory have provided insight on osteoarthritis onset and progression and will likely guide therapeutic development. We know that osteoarthritis is a disease of the whole organ meaning that any of the tissues involved in the synovial joint can be affected. The interplay between the various cell types involved is complex and understanding the interactions between cartilage, bone and synovium may be critical to therapeutic development. Skeletal development likely plays a very important role in predisposition to disease. Through the identification of serious pathologies such as various forms of dwarfism (what in medical terms are called chondrodysplasias) the role of transcription factors and epigenetics is increasing our understanding of disease genesis.The study of the epigenetics of OA - the mechanism by which the human genome alters it’s gene expression (without changing the primary DNA sequence) has provided valuable information on novel risk factors for the disease and are potential therapeutic targets for OA. RESOURCES Journal articles Nuclear receptors as potential drug targets in osteoarthritis Interplay between genetics and epigenetics in osteoarthritis Recent developments in emerging therapeutic targets of osteoarthritis CONNECT WITH US Twitter: @ProfDavidHunter @jointactionorg Email: hello@jointaction.info Website: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Robotics in knee replacement with Prof Chris Vertullo

    Nov 8, 202634 minAudio

    Robotic surgery promises precision. But does it translate into better outcomes for patients having knee replacement? In this episode of Joint Action, Professor David Hunter speaks with Professor Christopher Vertullo, an...

    Credit the people on this episode

  2. The Consumer Voice with John Day

    Oct 25, 202636 minAudio

    Patients are not just the subjects of research. They are essential partners in shaping it. In this episode of Joint Action, Professor David Hunter sits down with John Day, a consumer advocate who has spent years...

    Credit the people on this episode

  3. World Arthritis Day Special: Stories of Resilience and Hope

    Oct 11, 202623 minAudio

    On this special World Arthritis Day episode of Joint Action, we are bringing together some of the most moving moments from our patient stories series, where real people share what it is like to live with osteoarthritis,...

    Credit the people on this episode

  4. Supplements in osteoarthritis with A/Prof Joanna Harnett and Dr Jocelyn Bowden

    Sep 27, 202631 minAudio

    Do supplements really help with osteoarthritis, or are we wasting our money? On this week's episode of Joint Action, Associate Professor Joanna Harnett and Dr Jocelyn Bowden join Professor David Hunter to cut through...

    Credit the people on this episode

  5. Giovanna's journey with hand osteoarthritis

    Sep 13, 202636 minAudio

    What does it really mean to live with hand osteoarthritis, and how do you stay active and engaged in life when your hands are constantly painful? On this week's episode of Joint Action, Giovanna Lever joins Professor...

    Credit the people on this episode